PHARMACIST CARE

PLAN
HEALT PHARMACOTH RECOMMENDATION MONITORING END POINT FREQUENC
HCARE ERAPEUTIC AND INTERVENTION PARAMETERS Y
NEED GOAL

Manageme - To control burning PHARMACOLOGIC: Subjective

nt of Peptic pain in stomach after -We respectfully suggest to Therapeutic:
Ulcer meals, characterized by discontinue Mylanta, PRN and shift -Burning stomach (-) Burning DAILY
Disease circumscribed lesions to Ranitidine, 150 mg BID or 300 sensation stomach
(PUD) of the mucosa of the mg OD after the evening meal or at sensation
upper gastrointestinal bed time, for the management of his Objective
tract. burning pain in stomach after meals; Therapeutic:
as per Lexicomp -AST -10-30 U/L ????
-We respectfully suggest informing -ALT -6-40 U/L
the patient to store medication -Serum creatinine -0.5-1.2 mg/dL
between 20C and 25C. Protect from -Intragastric pH -<4
light and moisture; as per Lexicomp

NON-PHARMACOLOGIC Subjective toxic:

-We respectfully suggest to stop Watch out for SE: No occurrence of
alcohol intake since it is a known -Swelling of face, SE DAILY
mucosal irritant and can cause lips, tongue, throat
marked irritation of the gastric
mucosa if ingested in large
quantities at conc’n of 20% or
greater.

SNAHS
page 2
HEALT PHARMACOTH RECOMMENDATION MONITORING END POINT FREQUENC
HCARE ERAPEUTIC AND INTERVENTION PARAMETERS Y
NEED GOAL

Manageme - To restore hemoglobin PHARMACOLOGIC Subjective

nt of concentrations and red -We respectfully suggest ferrous Therapeutic:
anemia cell indices to normal, sulfate, 200mg OD; may be -Pale skin (-) Pale skin DAILY
(IDA ) and replenish iron administer in up to 3 divided doses -Fatigue (-) Fatigue
stores. in order to obtain normocytic, -Headache (-) Headache
normochromic red blood cells. -Myopic vision (-) Myopic vision
-We respectfully suggest informing -Spooning of (-) Spooning of
the patient to store medication out fingernails fingernails
of children’s reach and in child- ????
resistant container to prevent fatal Objective -12-18 g/dL
poisoning in children; as per Therapeutic: -37-52%
Lexicomp -Hemoglobin -3.5-5.9
-Hematocrit million/mm3
NOTE: -RBC count -150 ng/dL
-Alternate-day dosing (eg, every -240-450 mcg/dL
other day or Monday, Wednesday, -Serum ferritin
Friday) has been shown to result in -Total iron-binding
greater absorption of iron; as per capacity DAILY
Schrier 2019; Stoffel 2017 No occurrence of
-Monitor for possible reduced Subjective toxic: SE
efficacy of oral iron preparations in Watch out for SE:
the treatment of IDA when patients -Stomach cramps
are also receiving H2 antagonist; as -Constipation
per Lexicomp -Diarrhea

SNAHS
page 3
HEALT PHARMACOTH RECOMMENDATION MONITORING END POINT FREQUENC
HCARE ERAPEUTIC AND INTERVENTION PARAMETERS Y
NEED GOAL

Manageme - To restore hemoglobin NON-PHARMACOLOGIC Subjective

nt of concentrations and red -We respectfully suggest informing Therapeutic:
anemia cell indices to normal, the patient to avoid cereals. Dietary -Pale skin (-) Pale skin DAILY
(IDA ) and replenish iron fiber, tea, coffee, eggs or milk; as -Fatigue (-) Fatigue
stores. per Lexicomp -Headache (-) Headache
-Myopic vision (-) Myopic vision
-Spooning of (-) Spooning of
fingernails fingernails
????
Objective -12-18 g/dL
Therapeutic: -37-52%
-Hemoglobin -3.5-5.9
-Hematocrit million/mm3
-RBC count -150 ng/dL
-240-450 mcg/dL
-Serum ferritin
-Total iron-binding
capacity DAILY
No occurrence of
Subjective toxic: SE
Watch out for SE:
-Stomach cramps
-Constipation
-Diarrhea

SNAHS
page 4
HEALT PHARMACOTH RECOMMENDATION MONITORING END POINT FREQUENC
HCARE ERAPEUTIC AND INTERVENTION PARAMETERS Y
NEED GOAL

Manageme - To control PHARMACOLOGIC Subjective

nt of inflammation, relieve -We respectfully suggest Therapeutic:
arthritis pain, and reduce discontinue Aleve 2 tablets, PO, -Burning stomach (-) Burning DAILY
disability associated BID and shift to Infliximab, IV 3 pain stomach pain
with the condition mg/kg every 8 weeks thereafter; -Nausea (-) Nausea
Methotrexate doses have ranged
from 3 to 10 mg/kg repeated at 4-to Objective
8-week intervals; as per Lexicomp Therapeutic:
-We respectfully suggest informing -Serum creatinine -o.5-1.2 mg/dL ?????
the patient to store Infliximab vial -BUN -6-25 mg/dL
medications at 2C to 8C; may be -VS every 2-10 -BP: <120/<80
stored at room temperature for up to minutes mmHg
6 months; do not return to -PR: 60-100
refrigerated storage; as per BPM
Lexicomp -RR: 12-20 CPM
-We respectfully suggest informing -T: 36.5-37.5 C
the patient to store Methotrexate
tablet between 20C and 25C; protect Subjective toxic:
from light; as per Lexicomp Watch out for SE: No occurrence of
HA S.E
Joint or muscle pain DAILY
Skin rash

SNAHS
page 5
HEALT PHARMACOTH RECOMMENDATION MONITORING END POINT FREQUENC
HCARE ERAPEUTIC AND INTERVENTION PARAMETERS Y
NEED GOAL

Manageme - To control NON-PHARMACOLOGIC Subjective

nt of inflammation, relieve -We respectfully suggest informing Therapeutic:
arthritis pain, and reduce the patient to engage herself into -Burning stomach (-) Burning DAILY
disability associated flexibility/range of motion exercises pain stomach pain
with the condition which can be beneficial in -Nausea (-) Nausea
improving symptoms associated
with rheumatic dxs inluding pain, Objective
stiffness, and lack of mobility ; as Therapeutic:
per ncbi.nlm.nih.gov -Serum creatinine -o.5-1.2 mg/dL ?????
-BUN -6-25 mg/dL
-VS every 2-10 -BP: <120/<80
minutes mmHg
-PR: 60-100
BPM
-RR: 12-20 CPM
-T: 36.5-37.5 C

Subjective toxic:
Watch out for SE: No occurrence of
HA S.E
Joint or muscle pain DAILY
Skin rash

SNAHS
page 6